Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Keap1-Nrf2 System: Potential Role in Prevention of Sickle Cell Disease Organs Damages and Inflammation

Nadine Keleku-Lukwete, MD, Mikiko Suzuki, PhD, Akihito Otsuki, DDS, Kouhei Tsuchida, Saori Katayama, MD, Makiko Hayashi, Eriko Naganuma, Takashi Moriguchi, MDPhD, Osamu Tanabe, MDPhD, James Doug Engel, PhD, Masue Imaizumi, MDPhD, Masayuki Yamamoto, MD PhD

Blood (2015) 126 (23): 411.

https://doi.org/10.1182/blood.V126.23.411.411

Published: 2015

Journal Articles

The Role of Helicobacter Pylori in Japanese Children with Chronic Idiopathic Thrombocytopenic Purpura

Hisaya Nakadate, M.D., Ph.D., Jun-Ichi Kitazawa, M.D., Ph.D., Yasuo Horikoshi, M.D., Ph.D., Masayuki Nagasawa, M.D., Ph.D., Masue Imaizumi, M.D., Ph.D., Naoaki Kobayashi, M.D., Ph.D., Masao Kobayashi, M.D., Ph.D., Yukihiro Takahashi, M.D., Ph.D., Kohji Fujisawa, M.D., Ph.D., Akira Shirahata, M.D., Ph.D., Fumio Bessho, M.D., Ph.D.

Blood (2011) 118 (21): 4680.

https://doi.org/10.1182/blood.V118.21.4680.4680

Published: 2011

Journal Articles

Unexpected High Mortality Rate Due to Acute Respiratory Distress Syndrome Among Infants with AML Enrolled on JPLSG AML-05 Trial

Daisuke Tomizawa, MD, Akiko Moriya Saito, MD, PhD, Takashi Taga, MD, Souichi Adachi, MD, PhD, Hideki Nakayama, MD, Hiroshi Moritake, MD, PhD, Eiichi Azuma, MD, Akitoshi Kinoshita, MD, Hiroyuki Takahashi, MD, Masue Imaizumi, MD, Kazuko Kudo, MD, Asahito Hama, MD, Masahito Tsurusawa, MD, Keizo Horibe, MD, PhD, Akio Tawa, MD

Blood (2010) 116 (21): 2146.

https://doi.org/10.1182/blood.V116.21.2146.2146

Published: 2010

Journal Articles

Results of the Japanese Childhood Acute Myeloid Leukemia 99 Protocol for Down Syndrome and Acute Myeloid Leukemia.

Kazuko Kudo, Seiji Kojima, Ken Tabuchi, Eisaburo Ishii, Hiromasa Yabe, Akio Tawa, Masue Imaizumi, Ryoji Hanada, Kazuko Hamamoto, Ryoji Kobayashi, Akira Morimoto, Hideki Nakayama, Shigeru Tsuchiya, Masahiro Tsuchida, Keizo Horibe, Ichiro Tsukimoto

Blood (2005) 106 (11): 276.

https://doi.org/10.1182/blood.V106.11.276.276

Published: 2005

Journal Articles

Excellent Outcome of Risk Stratified Treatment for Childhood Acute Myeloid Leukemia-AML99 Trial. For the Japanese Childhood AML Cooperative Study Group.

Ichiro Tsukimoto, MD, Akio Tawa, MD, Ryoji Hanada, MD, Ken Tabuchi, MD, Hisato Kigasawa, MD, Shigeru Tsuchiya, MD, Masahiro Tsuchida, MD, Hiromasa Yabe, MD, Hideki Nakayama, MD, Kazuko Kudo, MD, Ryoji Kobayashi, MD, Kazuko Hamamoto, MD, Masue Imaizumi, MD, Akira Morimoto, MD, Keizo Horibe, MD

Blood (2005) 106 (11): 889.

https://doi.org/10.1182/blood.V106.11.889.889

Published: 2005

Journal Articles

Improved Outcome of Combination Therapy with ATRA, Anthracyclines and Cytarabine, AML99-M3 Protocol, for Childhood Acute Promyelocytic Leukemia.

Masue Imaizumi, MD, Akio Tawa, MD, Ryoji Hanada, MD, Masahiro Tsuchida, MD, Ken Taguchi, MD, Ryoji Kobayashi, MD, Akira Morimoto, MD, Hideki Nakayama, MD, Kazuko Hamamoto, MD, Kazuko Kudo, MD, Hiromasa Yabe, MD, Hisato Kigasawa, MD, Keizo Horibe, MD, Shigeru Tsuchiya, MD, Ichiro Tsukimoto, MD

Blood (2005) 106 (11): 891.

https://doi.org/10.1182/blood.V106.11.891.891

Published: 2005

Journal Articles

Involvement of Altered PML/RARalpha and RARbeta Expression in Delayed Restoration of Retinoic Acid Sensitivity in UF-1, an Acute Promyelocytic Leukemia Cell Line Carrying a Patient-Derived Mutant PML/RARalpha(Arg611Trp).

Yoshiyuki Hoshi, MD, Masue Imaizumi, MD, Kazuie Iinuma, MD

Blood (2004) 104 (11): 4469.

https://doi.org/10.1182/blood.V104.11.4469.4469

Published: 2004

Journal Articles

Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome

Blood (2003) 102 (8): 2960–2968.

https://doi.org/10.1182/blood-2003-02-0390

Published: 2003

Journal Articles

Superior outcome of infant acute myeloid leukemia with intensive chemotherapy: results of the Japan Infant Leukemia Study Group

Hajime Kawasaki, Keiichi Isoyama, Mariko Eguchi, Shigeyoshi Hibi, Naoko Kinukawa, Yoshiyuki Kosaka, Takanori Oda, Megumi Oda, Shin-ichiro Nishimura, Masue Imaizumi, Takayuki Okamura, Teruaki Hongo, Hiroji Okawa, Shuki Mizutani, Yasuhide Hayashi, Ichiro Tsukimoto, Nanao Kamada, Eiichi Ishii

Blood (2001) 98 (13): 3589–3594.

https://doi.org/10.1182/blood.V98.13.3589

Published: 2001

Journal Articles

Mutations in the E-Domain of RARα Portion of the PML/RARα Chimeric Gene May Confer Clinical Resistance to All- trans Retinoic Acid in Acute Promyelocytic Leukemia

Masue Imaizumi, Hoshiro Suzuki, Miyako Yoshinari, Atsushi Sato, Toshiaki Saito, Akira Sugawara, Shigeru Tsuchiya, Yoshiro Hatae, Takeo Fujimoto, Akira Kakizuka, Tasuke Konno, Kazuie Iinuma

Blood (1998) 92 (2): 374–382.

https://doi.org/10.1182/blood.V92.2.374

Published: 1998

NARROW

Keap1-Nrf2 System: Potential Role in Prevention of Sickle Cell Disease Organs Damages and Inflammation

The Role of Helicobacter Pylori in Japanese Children with Chronic Idiopathic Thrombocytopenic Purpura

Unexpected High Mortality Rate Due to Acute Respiratory Distress Syndrome Among Infants with AML Enrolled on JPLSG AML-05 Trial

Results of the Japanese Childhood Acute Myeloid Leukemia 99 Protocol for Down Syndrome and Acute Myeloid Leukemia.

Excellent Outcome of Risk Stratified Treatment for Childhood Acute Myeloid Leukemia-AML99 Trial. For the Japanese Childhood AML Cooperative Study Group.

Improved Outcome of Combination Therapy with ATRA, Anthracyclines and Cytarabine, AML99-M3 Protocol, for Childhood Acute Promyelocytic Leukemia.

Involvement of Altered PML/RARalpha and RARbeta Expression in Delayed Restoration of Retinoic Acid Sensitivity in UF-1, an Acute Promyelocytic Leukemia Cell Line Carrying a Patient-Derived Mutant PML/RARalpha(Arg611Trp).

Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome

Superior outcome of infant acute myeloid leukemia with intensive chemotherapy: results of the Japan Infant Leukemia Study Group

Mutations in the E-Domain of RARα Portion of the PML/RARα Chimeric Gene May Confer Clinical Resistance to All- trans Retinoic Acid in Acute Promyelocytic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only